Vineet Laboratories
Vineet Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Vineet Laboratories
Start SIPVineet Laboratories Investment Rating
-
Master Rating:
-
Vineet Laboratories has an operating revenue of Rs. 182.28 Cr. on a trailing 12-month basis. An annual revenue de-growth of -21% needs improvement, Pre-tax margin of 5% is okay, ROE of 19% is exceptional. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 22 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|
| Oper Rev Qtr Cr | 40 | 49 | 56 |
| Operating Expenses Qtr Cr | 44 | 45 | 50 |
| Operating Profit Qtr Cr | -4 | 4 | 6 |
| Depreciation Qtr Cr | 1 | 1 | 1 |
| Interest Qtr Cr | 1 | 1 | 1 |
| Tax Qtr Cr | -1 | 1 | 2 |
| Net Profit Qtr Cr | -5 | 1 | 3 |
Vineet Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 57.1
- 50 Day
- 57.84
- 100 Day
- 58.83
- 200 Day
- 61.54
- 20 Day
- 57.42
- 50 Day
- 57.14
- 100 Day
- 59.64
- 200 Day
- 59.68
Vineet Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 56.65 |
| Second Resistance | 58.45 |
| Third Resistance | 59.55 |
| RSI | 38.64 |
| MFI | 53.38 |
| MACD Single Line | -0.16 |
| MACD | -0.59 |
| Support | |
|---|---|
| First Resistance | 53.75 |
| Second Resistance | 52.65 |
| Third Resistance | 50.85 |
Vineet Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 43,689 | 2,546,195 | 58.28 |
| Week | 21,214 | 1,270,731 | 59.9 |
| 1 Month | 26,556 | 1,409,833 | 53.09 |
| 6 Month | 40,905 | 1,906,190 | 46.6 |
Vineet Laboratories Result Highlights
Vineet Laboratories Synopsis
NSE-Medical-Diversified
Vineet Laboratories belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 191.17 Cr. and Equity Capital is Rs. 9.22 Cr. for the Year ended 31/03/2022. Vineet Laboratories Ltd. is a Public Limited Listed company incorporated on 10/11/2016 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24304TG2016PLC112888 and registration number is 112888.| Market Cap | 50 |
| Sales | 182 |
| Shares in Float | 0.59 |
| No of funds | 1 |
| Yield | 1.84 |
| Book Value | 1.51 |
| U/D Vol ratio | 2.1 |
| LTDebt / Equity | 5 |
| Alpha | -0.05 |
| Beta | 1.12 |
Vineet Laboratories
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 35.96% | 35.96% | 35.96% | |
| Foreign Portfolio Investors | ||||
| Individual Investors | 61.23% | 61.39% | 61.31% | |
| Others | 2.81% | 2.65% | 2.73% |
Vineet Laboratories Management
| Name | Designation |
|---|---|
| Mr. Gaddam Venkata Ramana | Managing Director |
| Mr. Satyanarayana Raju Bhupathiraju | WholeTime Director & CFO |
| Mr. Kandula Murali Mohan | Non Exe.Non Ind.Director |
| Mr. Dilip Vishnu Acharekar | Ind. Non-Executive Director |
| Mr. Bhaskara Reddy Karna | Ind. Non-Executive Director |
| Mrs. Hari Priya Yerukalapudi | Ind. Non-Executive Director |
Vineet Laboratories Forecast
Price Estimates
Vineet Laboratories FAQs
What is Share Price of Vineet Laboratories ?
Vineet Laboratories share price is ₹54 As on 05 February, 2023 | 19:38
What is the Market Cap of Vineet Laboratories ?
The Market Cap of Vineet Laboratories is ₹49.8 Cr As on 05 February, 2023 | 19:38
What is the P/E ratio of Vineet Laboratories ?
The P/E ratio of Vineet Laboratories is 52.3 As on 05 February, 2023 | 19:38
What is the PB ratio of Vineet Laboratories ?
The PB ratio of Vineet Laboratories is 1.5 As on 05 February, 2023 | 19:38